Snapshot

DOI:

An expert review on managing cardiovascular masses using transcatheter vacuum-assisted aspiration; revascularisation vs medical therapy in 3-vessel disease; CT-μFR; follow-up after mitral transcatheter edge-to-edge repair; design of the DAPT-SHOCK-AMI trial; and more

From the aspiration of cardiovascular masses to new techniques for evaluating coronary lesions, or anatomical changes after mitral valve edge-to edge repair, a wide variety of topics are touched on in this issue – but what about that gorilla hiding in your cath lab? Do you know what that could be?

Transcatheter vacuum-assisted aspiration has become an alternative to surgery for certain high-risk patients with intracardiac and intravascular masses of various aetiologies, often seen as thrombi, tumours, or vegetations. In an expert review, Laura Besola, Andrea Colli and colleagues go over the current clinical evidence, indications and the different uses of vacuum-assisted aspiration in the treatment.

In a post hoc analysis of the ISCHEMIA trial, Sripal Bangalore, Judith S. Hochman and colleagues evaluate the outcomes of revascularisation versus medical therapy in patients with three-vessel coronary artery disease. Revascularisation, including both percutaneous coronary intervention and coronary artery bypass grafting, was associated with lower rates of cardiovascular death and myocardial infarction at four years, as well as an improved quality of life.

Tingwen Weng, Shengxian Tu and colleagues investigate the diagnostic performance of the Murray law-based quantitative flow ratio (CT-μFR), which is a novel coronary computed tomography angiography-derived method for quickly computing fractional flow reserve and identifying haemodynamically significant coronary stenoses and lesions.

Using transoesophageal echocardiography (TOE), Joanna Bartkowiak, Fabien Praz and colleagues evaluate anatomical changes and structural complications after mitral transcatheter edge-to-edge repair, investigating their association with clinical outcomes at two years.

Describing the upcoming DAPT-SHOCK-AMI trial, Zuzana Motovska, Deepak L. Bhatt and colleagues discuss the rationale and design of this study, which will randomise more than 500 patients to evaluate the benefits of cangrelor vs crushed ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock.

Volume 20 Number 20
Oct 21, 2024
Volume 20 Number 20
View full issue

Suggested by Cory

May 25, 2010
Magnetic resonance imaging for myocardial viability
Siebelink H-M and Lamb H
free

10.4244/EIJ-D-18-00066 Apr 20, 2018
Interventional cardiology: review of the year 2017
Modolo R et al
free

Jan 11, 2011
The Tryton Side Branch Stent
Magro M and van Geuns R
free

May 25, 2010
Echocardiography: guidance during valve implantation
Gonçalves A et al
free

Aug 23, 2013
Erratum
free

Jan 11, 2011
Drug-eluting balloons and bifurcations, a new future?
Stella P et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved